[铁蛋白、癌胚抗原和组织多肽抗原作为乳腺肿瘤的肿瘤标志物]
[Ferritin, CEA and TPA as tumor markers in breast neoplasms].
作者信息
Bonanni F, Folco U, Giudici Cipriani A, Buffa E, Amedeo A, Bertolotto M, Rembado R, Barbetti V, Guglieri F
出版信息
Minerva Med. 1985 Sep 15;76(34-35):1533-4.
PMID:4034052
Abstract
In order to assess the sensitivity and specificity of Ferritin, CEA and TPA as neoplastic markers in breast carcinomas, 91 patients all classified according to the TNM-UICC system were studied in a cancer clinic. The results of the analyses indicate that ferritin is apparently only influenced by the presence of metastatic neoplasias and that greater sensitivity is obtained if all three markers are employed simultaneously.
摘要
为了评估铁蛋白、癌胚抗原（CEA）和组织多肽抗原（TPA）作为乳腺癌肿瘤标志物的敏感性和特异性，在一家癌症诊所对91例均按照国际抗癌联盟（UICC）TNM系统分类的患者进行了研究。分析结果表明，铁蛋白显然仅受转移性肿瘤存在与否的影响，并且如果同时使用这三种标志物，则可获得更高的敏感性。
相似文献
1
[Ferritin, CEA and TPA as tumor markers in breast neoplasms].[铁蛋白、癌胚抗原和组织多肽抗原作为乳腺肿瘤的肿瘤标志物]
Minerva Med. 1985 Sep 15;76(34-35):1533-4.
2
[The tumor markers CEA, TPA and CA 19-9 and ferritin and osteocalcin in follow-up studies in breast cancer].[肿瘤标志物癌胚抗原、组织多肽抗原、糖类抗原19-9以及铁蛋白和骨钙素在乳腺癌随访研究中的应用]
Wien Klin Wochenschr. 1985 Dec 6;97(23):873-9.
3
4
[The tumor markers TPA and CEA in the after care of breast cancer].[肿瘤标志物组织多肽抗原（TPA）和癌胚抗原（CEA）在乳腺癌随访中的应用]
Wien Med Wochenschr. 1985 Feb 28;135(4):85-8.
5
[Auxiliary value of TPA in diagnosing neoplastic diseases].[组织型纤溶酶原激活剂在肿瘤疾病诊断中的辅助价值]
Gan No Rinsho. 1986 Jun;32(7):779-82.
6
[Clinical evaluation of tumor markers in breast cancer patients].[乳腺癌患者肿瘤标志物的临床评估]
Gan To Kagaku Ryoho. 1987 Oct;14(10):2917-23.
7
Human tissue polypeptide antigen in breast cancer.乳腺癌中的人组织多肽抗原
J Natl Cancer Inst. 1979 Dec;63(6):1347-50.
8
Comparison of serum CEA, PHI, and TPA as tumor markers in breast cancer patients.乳腺癌患者血清癌胚抗原、胰腺激素抑制因子和组织多肽抗原作为肿瘤标志物的比较。
Cancer Detect Prev. 1987;10(3-4):197-203.
9
[Tissue polypeptide and carcinoembryonic antigens in patients with breast cancer].[乳腺癌患者的组织多肽和癌胚抗原]
Vopr Onkol. 1984;30(3):9-13.
10
[Advantages and limitations of combined assays of 4 serum markers in various types of malignant neoplasms].[4种血清标志物联合检测在各类恶性肿瘤中的优势与局限性]
Minerva Med. 1986 Sep 15;77(34-35):1521-5.
Zotero 插件